OBJECTIVE: @entity432 ( @entity432 ) during @entity788 resection is controversial. We examined the safety and efficacy of @entity432 during pancreatectomy. METHODS: We used a prospective institutional database that includes 6522 @entity1 who underwent pancreatectomy from 1970 to 2014; 35 had @entity432 . We performed a 2:1 propensity match for @entity1 without and with @entity432 on the basis of preoperative @entity1 and @entity5 variables. We then compared operative and postoperative outcomes between matched groups. RESULTS: @entity432 included 18 hepatic, 8 celiac, 3 splenic, 3 middle colic, 2 superior mesenteric, and 1 left renal artery. There were 20 primary, 4 vein, and 2 graft reconstructions; 11 were emergent and 24 elective. Before matching, @entity1 with @entity432 were younger (58     2 vs 63     0.2  years old; P  = .05), more likely to be of black race (26% vs 9%; P  = .003), to have received preoperative chemotherapy (17% vs 2%; P  < .001), have a later stage and larger @entity5 (4     0.8 vs 3     0.04  cm; P  = .05), more resections that included removal of all macroscopic disease, but microscopic @entity41 remained (31% vs 14%; P  = .02), greater @entity190 (1285     276 vs 822     16  mL; P  = .02), and more frequent @entity299 (11% vs 4%; P  = .03) compared with @entity1 without @entity432 . After propensity matching, baseline @entity1 characteristics were similar between groups. For perioperative outcomes, the groups did not differ in surgical time, @entity190 , length of stay, or complications including @entity834 , @entity548 , @entity299 , or liver @entity1188 or failure (all; P  = not significant). Patency was 97% at a mean follow-up of 510     184  days with 1 hepatic artery @entity432 @entity715 . Long-term outcomes were significantly different: @entity1 with @entity432 had a lower rate of @entity5 recurrence (20% vs 47%; P  = .007) but also lower 1-year (50% vs 87%; P  = .002) and median survival (22     18 vs 49     7  months; P  = .002). CONCLUSIONS: @entity432 during pancreatectomy is safe and not associated with increased complications. Although it significantly reduces the risk of @entity5 recurrence, @entity432 is associated with worse survival compared with @entity1 who do not undergo @entity432 .

Outcomes of arterial resection during pancreatectomy for XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity788 :: ('MESH:D010190', 'Disease') :: ['pancreatic tumor'] @entity834 :: ('MESH:D057868', 'Disease') :: ['anastomotic leaks'] @entity41 :: ('MESH:D018365', 'Disease') :: ['residual tumor'] @entity548 :: ('MESH:D006470', 'Disease') :: ['bleeding'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'local tumor'] @entity190 :: ('MESH:D006473', 'Disease') :: ['blood loss'] @entity1188 :: ('MESH:D007238', 'Disease') :: ['infarct'] @entity299 :: ('MESH:D006331', 'Disease') :: ['cardiac, infectious complications', 'cardiac complications'] @entity432 :: ('MESH:D001157', 'Disease') :: ['Arterial resection', 'AR'] @entity715 :: ('MESH:D013927', 'Disease') :: ['thrombosis']
@entity5 :: (MESH:D009369,Disease) :: ['tumor']
